Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Completion of Non-Renounceable Pro-Rata Entitlement Offer

by admin September 15, 2025
September 15, 2025
Completion of Non-Renounceable Pro-Rata Entitlement Offer

Carbonxt Group (CG1:AU) has announced Completion of Non-Renounceable Pro-Rata Entitlement Offer

Download the PDF here.

This post appeared first on investingnews.com

previous post
Newmont to Delist from Toronto Stock Exchange as Cost Cuts Deepen
next post
Significant Enlargement of Exploration Program

Related Posts

Top 5 Canadian Silver Stocks of 2025

April 14, 2025

Jindalee Realises $2.75M from Sale of Non-Core Asset

February 25, 2025

SAGA Metals Completes Final Preparations for Maiden Drill...

January 27, 2025

Crypto Market Recap: Kraken Expands Services, EURC Momentum...

April 15, 2025

Empire Metals

September 3, 2025

Gold Price Breaks US$2,900 as Tariff Turmoil Boosts...

February 11, 2025

Letter from the CEO: Unlocking the True Value...

March 27, 2025

Is it Time to Take Profits? Experts Share...

January 31, 2026

Canadian Investment Regulatory Organization Trade Resumption – SRR

February 8, 2025

Boundiali extends strike and depth at BDT3 and...

February 16, 2026

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved